Enzo Tramontano

Full Professor

University of Cagliari

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Enzo Tramontano is a Full Professor at the University of Cagliari, Italy. His research areas span virology and molecular biology, with a focus on SARS-CoV-2, HIV-1, and chronic fatigue syndrome. He has contributed significantly through various publications, including studies on RNA-dependent RNA polymerase, heart rate variability biofeedback in Long COVID, and novel antiviral compounds.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (22)

Nicole Grandi

Associate Professor in Microbiology

University of Cagliari

ITALY

Enzo Tramontano

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Characterization of SARS-CoV-2 nucleocapsid protein oligomers

Identification of HIV-1 Reverse Transcriptase-Associated Ribonuclease H Inhibitors Based on 2-Hydroxy-1,4-naphthoquinone Mannich Bases

HERV Modulation in Colorectal Carcinoma Patients: A Snapshot of Endogenous Retroviral Transcriptome

Unveiling SARS-CoV-2's heart: role, structure and inhibition of SARS-CoV-2 RNA-dependent RNA polymerase

The Use of Heart Rate Variability-Biofeedback (HRV-BF) as an Adjunctive Intervention in Chronic Fatigue Syndrome (CSF/ME) in Long COVID: Results of a Phase II Controlled Feasibility Trial

Design, Synthesis and Biological Evaluation of 3-Hydrazonoindolin-2-one Derivatives as Novel HIV-1 RNase H Inhibitors

Cognitive Impairment and Risk of Depressive Episodes from a Bipolar Spectrum Perspective: A Case-Control Study in Older Adults during the COVID-19 Lockdown

Identification of new benzofuran derivatives as STING agonists with broad-spectrum antiviral activity

New Thiazolidine-4-One Derivatives as SARS-CoV-2 Main Protease Inhibitors

Structure-Based Design of Novel Thiazolone[3,2-a]pyrimidine Derivatives as Potent RNase H Inhibitors for HIV Therapy

DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action

HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus, an Endemic Plant of Sardinia (Italy) and Corsica (France)

Visible Light-Mediated Inactivation of H1N1 Virus UsingPolymer-Based Heterojunction Photocatalyst

Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action

Analogs of the Catechol Derivative Dynasore Inhibit HIV-1 Ribonuclease H, SARS-CoV-2 nsp14 Exoribonuclease, and Virus Replication

Targeting SARS-CoV-2 Main Protease: A Successful Story Guided by an In Silico Drug Repurposing Approach

Dihydroxyphenyl- and Heteroaromatic-Based Thienopyrimidinones to Tackle HIV-1 LEDGF/p75-Dependent IN Activity

Envelope Recombination: A Major Driver in Shaping Retroviral Diversification and Evolution within the Host Genome

Unlocking STING as a Therapeutic Antiviral Strategy

Human Endogenous Retrovirus (HERV) Transcriptome Is Dynamically Modulated during SARS-CoV-2 Infection and Allows Discrimination of COVID-19 Clinical Stages

Collaborators (22)

Nicole Grandi

ANDREA ROSARIO BECCARI

Roberto Di Santo

SIMONA DISTINTO

Francesca Alessandra Ambrosio

Wolfgang Schröder

Brigida D’Abrosca

CARLO MARIA CARBONARO

Bernhard Biersack

Serena Canton

luigi scipione

Francesca Caccuri

Angela Corona

Francesca Esposito

Philip Gribbon

Giosuè Costa

CINZIA SANNA

Giuseppe La Torre

Giovanna Lucia Delogu

Pier Carlo Ricci

Daniele Chiriu

Antonio Fiorentino

Make your next move.